Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 129 - 136 of 11439 results
Mintz IRA Update — The Growing Use of State Prescription Drug Affordability Boards
July 15, 2024| Blog| Viewpoint
Mintz IRA Update — The Consequences and Costs of Redesigning the Part D Program
July 15, 2024| Blog| Viewpoint
Mintz IRA Update — Learning From Experience: Medicare Drug Price Negotiation Program Updates
July 15, 2024| Blog| Viewpoint
Florida Emerges as the Place to Enforce Foreign Arbitral Awards
July 15, 2024| News
PBM Update: Special Edition - FTC 6(b) Interim Staff Report and Activity
July 12, 2024| Alert| Viewpoint
SEC Issues Updated Guidance on Cybersecurity Incident Disclosure Under Item 1.05 of Form 8-K
July 11, 2024| Alert| Viewpoint
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.